![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Substantial comorbidities and rising economic burden in real-world non-alcoholic fatty liver disease (NAFLD)/ non-alcoholic steatohepatitis (NASH) patients with compensated cirrhosis (CC):
A large German claims database study
|
|
|
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Canbay A1, Meise D2, Haas JS2
1Department of Gastroenterology, Hepatology and Infectiology, University of Magdeburg Medical School, 2Xcenda GmbH
![0423181](../images%20/042318/042318-9/0423181.gif)
![0423182](../images%20/042318/042318-9/0423182.gif)
![0423183](../images%20/042318/042318-9/0423183.gif)
![0423184](../images%20/042318/042318-9/0423184.gif)
![0423185](../images%20/042318/042318-9/0423185.gif)
![0423186](../images%20/042318/042318-9/0423186.gif)
![0423187](../images%20/042318/042318-9/0423187.gif)
![0423188](../images%20/042318/042318-9/0423188.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|